Article
Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds.
The Journal of clinical endocrinology and metabolism - 1 May 2001
Viemann M, Peter M, López-Siguero J P, Simic-Schleicher G, Sippell W G
Abstract excerpt
Pseudohypoaldosteronism type 1 (PHA1) is characterized by neonatal salt wasting resistant to mineralocorticoids. There are 2 forms of PHA1: the autosomal recessive form with symptoms persisting into adulthood, caused by mutations in the amiloride-sensitive luminal sodium channel, and the autosomal dominant or sporadic form, which shows milder symptoms that remit with age. Mutations in the gene encoding the human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
